Location History:
- Victoria, AU (2012)
- Glen Waverley, AU (2013)
- Lynbrook, AU (2013 - 2014)
- Notting Hill, AU (2014 - 2016)
- Alpharetta, GA (US) (2017)
Company Filing History:
9 out of 54 
1 out of 5 Years Active: 2012-2017
Title: Silas Bond: Innovator in Antiviral Compounds
Introduction
Silas Bond is a notable inventor based in Lynbrook, Australia. He has made significant contributions to the field of antiviral research, holding a total of 10 patents. His work focuses on developing innovative compounds for the treatment of viral infections.
Latest Patents
Among his latest patents, Bond has developed polycyclic agents for the treatment of respiratory syncytial virus infections. This invention relates to polycyclic antiviral compounds, their salts, methods for their preparation, and compositions containing them. These compounds are intended for use in treating viral infections. Another significant patent involves viral polymerase inhibitors, which are designed to combat Flaviviridae viral infections, such as Hepatitis C virus (HCV) infections. This invention includes inhibitors of a specific formula, along with processes for their preparation and application in treatment.
Career Highlights
Throughout his career, Silas Bond has worked with several prominent companies, including Biota Scientific Management Pty Ltd and Aviragen Therapeutics, Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of effective antiviral therapies.
Collaborations
Bond has collaborated with notable individuals in his field, including Alistair George Draffan and Michael Harding. These partnerships have further enriched his research and innovation efforts.
Conclusion
Silas Bond's work in antiviral compounds showcases his dedication to improving treatment options for viral infections. His numerous patents reflect his innovative spirit and commitment to advancing medical science.